Myda Advisors LLC Rubius Therapeutics, Inc. Transaction History

Myda Advisors LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Nov 13, 2020	SELL	$4.65 - $6.25 $1.23 Million - $1.65 Million	-263,500 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$4.01 - $6.88 $1.06 Million - $1.81 Million	263,500 New	263,500 $1.76 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.